These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9711937)
1. Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure. Vesely DL; Dietz JR; Parks JR; Baig M; McCormick MT; Cintron G; Schocken DD Circulation; 1998 Jul; 98(4):323-9. PubMed ID: 9711937 [TBL] [Abstract][Full Text] [Related]
2. Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure. Vesely DL; Dietz JR; Parks JR; Antwi EA; Overton RM; McCormick MT; Cintron G; Schocken DD Am Heart J; 1999 Oct; 138(4 Pt 1):625-32. PubMed ID: 10502206 [TBL] [Abstract][Full Text] [Related]
3. Combined treatment with vessel dilator and kaliuretic hormone in persons with congestive heart failure. Patel H; Dietz JR; Owen A; San Miguel G; McCormick MT; Schocken DD; Vesely DL Exp Biol Med (Maywood); 2004 Jun; 229(6):521-7. PubMed ID: 15169971 [TBL] [Abstract][Full Text] [Related]
4. Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure. Nasser A; Dietz JR; Siddique M; Patel H; Khan N; Antwi EK; San Miguel GI; McCormick MT; Schocken DD; Vesely DL Am J Cardiol; 2001 Jul; 88(1):23-9. PubMed ID: 11423053 [TBL] [Abstract][Full Text] [Related]
6. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer? Vesely DL Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258 [TBL] [Abstract][Full Text] [Related]
7. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance urinary excretion rate of albumin, total protein, and beta(2)-microglobulin in patients with congestive heart failure. Vesely DL; Perez-Lamboy GI; Schocken DD J Card Fail; 2001 Mar; 7(1):55-63. PubMed ID: 11264551 [TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptides in the diagnosis and treatment of congestive heart failure. Vesely DL Congest Heart Fail; 1999; 5(4):171-179. PubMed ID: 12189309 [TBL] [Abstract][Full Text] [Related]
9. Intact negative feedback of four cardiac hormones in congestive heart failure. Vesely DL; San Miguel GI; Hassan I; Schocken DD Metabolism; 2002 May; 51(5):582-8. PubMed ID: 11979389 [TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone. Vesely DL Clin Exp Pharmacol Physiol; 1995 Feb; 22(2):108-14. PubMed ID: 7621602 [TBL] [Abstract][Full Text] [Related]
11. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans. Vesely DL; Douglass MA; Dietz JR; Gower WR; McCormick MT; Rodriguez-Paz G; Schocken DD Circulation; 1994 Sep; 90(3):1129-40. PubMed ID: 8087923 [TBL] [Abstract][Full Text] [Related]
12. Cardiorenal effects of atrial natriuretic factor administration in congestive heart failure: natriuresis and diuresis without hemodynamic alterations. Firth BG; Perna R; Bellomo JF; Toto RD Am J Med Sci; 1989 Apr; 297(4):203-8. PubMed ID: 2565086 [TBL] [Abstract][Full Text] [Related]